Clinical Features and Risks of Congenital Melanocytic Naevi: A Retrospective Analysis of Patients at the Queensland Children's Hospital.

Yolanka Lobo, Jessica Zhuang, Hannah Gribbin, William Felipe Pinzon Perez, H Peter Soyer, Laura Wheller
Author Information
  1. Yolanka Lobo: Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. ORCID
  2. Jessica Zhuang: Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. ORCID
  3. Hannah Gribbin: Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. ORCID
  4. William Felipe Pinzon Perez: QCIF Bioinformatics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. ORCID
  5. H Peter Soyer: Department of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. ORCID
  6. Laura Wheller: QCIF Bioinformatics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. ORCID

Abstract

BACKGROUND/OBJECTIVES: Congenital melanocytic naevi (CMN) are a risk factor for melanoma. Melanoma risk is dependent on the congenital phenotype. Our primary aims were to assess the clinical characteristics of CMN that indicate a high risk of neurocutaneous melanosis (NCM) and melanoma in an Australian paediatric population group; to identify patient characteristics and clinical features of CMN that trigger further investigations; and to determine the rate of malignancy and other complications for CMN.
METHODS: We retrospectively reviewed the electronic medical records of all patients under 18���years who were diagnosed with CMN at the Queensland Children's Hospital between 2014 and 2021.
RESULTS: Eighty-eight patients (38 males and 50 females) were included in the analysis. Eighteen patients (20%) had a biopsy to rule out malignancy. Central nervous system magnetic resonance imaging (MRI) was performed in 16 patients (18%). Five patients (5.7%) experienced complications, of which three had NCM and two had transient neurological symptoms with normal MRI. No cases of melanoma, non-melanoma tumours or deaths were recorded.
CONCLUSIONS: CMN size, location over the posterior midline axis and multiple numbers of CMN were found to be significantly associated with the development of complications. CMN size, CMN site, presence of satellite naevi and location over the posterior midline axis were all significantly associated with the likelihood of an MRI or biopsy being performed. Large-scale studies, such as a population-based registry, are recommended to accurately assess the true lifetime risk of complications and associated risk factors.

Keywords

References

  1. Arch Dis Child. 2001 Feb;84(2):152-5 [PMID: 11159293]
  2. Br J Dermatol. 2015 Sep;173(3):739-50 [PMID: 25966033]
  3. Clin Imaging. 2014 Mar-Apr;38(2):79-84 [PMID: 24239041]
  4. Br J Dermatol. 2009 Feb;160(2):387-92 [PMID: 19016692]
  5. Plast Reconstr Surg. 2001 Apr 1;107(4):933-41 [PMID: 11252085]
  6. Br J Dermatol. 2009 Jan;160(1):143-50 [PMID: 18811688]
  7. J Am Acad Dermatol. 2006 May;54(5):767-77 [PMID: 16635656]
  8. Br J Dermatol. 2015 Dec;173(6):1522-4 [PMID: 26075503]
  9. J Am Acad Dermatol. 2013 Mar;68(3):441-51 [PMID: 22982004]
  10. Australas J Dermatol. 2009 Nov;50(4):231-40; quiz 241-2 [PMID: 19916964]
  11. J Am Acad Dermatol. 2022 Nov;87(5):1060-1068 [PMID: 35716834]
  12. Australas J Dermatol. 2012 Aug;53(3):219-23 [PMID: 22671135]
  13. J Am Acad Dermatol. 2005 Dec;53(6):959-65 [PMID: 16310055]
  14. Br J Dermatol. 2017 May;176(5):1131-1143 [PMID: 28078671]
  15. Pediatr Dev Pathol. 2015 Jan-Feb;18(1):1-9 [PMID: 25490715]
  16. Br J Dermatol. 2005 Mar;152(3):512-7 [PMID: 15787820]
  17. Arch Dermatol. 2004 Feb;140(2):171-5 [PMID: 14967788]
  18. J Eur Acad Dermatol Venereol. 2023 Jan;37(1):32-39 [PMID: 36149403]
  19. Br J Dermatol. 2008 Sep;159(4):907-14 [PMID: 18671780]
  20. Plast Reconstr Surg. 2004 Jun;113(7):1968-74 [PMID: 15253185]
  21. Dermatology. 1997;195(2):125-8 [PMID: 9310717]
  22. J Am Acad Dermatol. 2009 Nov;61(5):766-74 [PMID: 19766348]
  23. Pediatrics. 2000 Oct;106(4):736-41 [PMID: 11015516]
  24. Pediatr Radiol. 2018 Nov;48(12):1786-1796 [PMID: 30074086]
  25. J Am Acad Dermatol. 2005 May;52(5):793-7 [PMID: 15858468]
  26. J Am Acad Dermatol. 2013 Mar;68(3):493-8.e1-14 [PMID: 23182059]
  27. Br J Dermatol. 2006 Jul;155(1):1-8 [PMID: 16792745]

MeSH Term

Humans
Male
Female
Retrospective Studies
Nevus, Pigmented
Skin Neoplasms
Queensland
Child
Child, Preschool
Infant
Melanoma
Adolescent
Risk Factors
Melanosis
Hospitals, Pediatric
Neurocutaneous Syndromes
Infant, Newborn
Magnetic Resonance Imaging

Word Cloud

Created with Highcharts 10.0.0CMNriskpatientsmelanomacomplicationsMRIassociatedCongenitalnaevicongenitalassessclinicalcharacteristicsneurocutaneousmelanosisNCMmalignancyQueenslandChildren'sbiopsyperformedsizelocationposteriormidlineaxissignificantlystudiesfactorsBACKGROUND/OBJECTIVES:melanocyticfactorMelanomadependentphenotypeprimaryaimsindicatehighAustralianpaediatricpopulationgroupidentifypatientfeaturestriggerinvestigationsdeterminerateMETHODS:retrospectivelyreviewedelectronicmedicalrecords18���yearsdiagnosedHospital between20142021RESULTS:Eighty-eight38males50femalesincludedanalysisEighteen20%ruleCentralnervoussystemmagneticresonanceimaging1618%Five57%experiencedthreetwotransientneurologicalsymptomsnormalcasesnon-melanomatumoursdeathsrecordedCONCLUSIONS:multiplenumbersfounddevelopmentsitepresencesatellitelikelihoodLarge-scalepopulation-basedregistryrecommendedaccuratelytruelifetimeClinicalFeaturesRisksMelanocyticNaevi:RetrospectiveAnalysisPatientsHospitalpigmentednevusretrospective

Similar Articles

Cited By